Please turn JavaScript on
header-image

Causeartist

Receive updates from Causeartist for free, starting right now.

We can deliver them by email, via your phone or you can read them from a personalised news page on follow.it.

This way you won't miss any new article from Causeartist. Unsubscribe at any time.

Site title: Causeartist - Spotlighting impactful startups.

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.47 / day

Message History

Hey friends,

This week is all about infrastructure for permanence, how we swap throwaway habits, extractive finance, and fragile systems for materials, capital flows, and innovation models built to last.

We will explore how circularity is slashing emissions in Europe, why Japan is seeing a record surge in impact awareness, and how "Physical A...


Read full story

Hey friends,

Welcome to this week's edition. We’re exploring how "old-school" industries—from chocolate to aid distribution—are being radically modernized.

This week, we dive into Tony’s Chocolonely, a brand that turned a supply chai...


Read full story

Waste-to-Energy (WtE) is the process of converting non-recyclable municipal solid waste (MSW) into usable forms of energy, most commonly electricity, heat, or transportation fuel.

Rather than sending residual waste to landfill, WtE facilities use thermal, biological, or chemical processes to extract energy value from materials that have exhausted their ...


Read full story

When a disaster hits, the gap between funding allocated and funding received can cost lives. AidKit is building the infrastructure to close that gap. The company works with governments, nonprofits, and NGOs to stand up eligibility verification, multilingual applications, and payment disbursement in a matter of hours, not weeks.

Brittany Christenson, CEO of


Read full story

For decades, lupus has remained one of the most complex challenges in modern medicine. Its extreme heterogeneity, where symptoms and triggers can vary widely from one patient to the next, has made the disease difficult to study, diagnose, and treat.

As a result, lupus has often been passed over by traditional venture capital in favor of conditions with more predictable ...


Read full story